Plus, news about Harbour BioMed:
Ascletis’ muscle-preserving drug yields limp weight loss data: The Hong Kong-based biotech said its adipose-targeted obesity therapy, called ASC47, demonstrated placebo-adjusted weight loss of 1.7% 50 ...
↧